The global infertility drugs market size surpassed USD 3.71 billion in 2023 and is expected to be worth around USD 6.73 billion by 2033, growing at a CAGR of 6.13% from 2024 to 2033.
Key Points
- The global infertility drugs market size accounted for USD 1.45 billion in 2023 and is expected to rise around USD 2.65 billion by 2033.
- North America dominated the market with the largest market share of 39% in 2023.
- Asia Pacific is expected to expand at the fastest CAGR of 6.93% during the forecast period.
- By drug class, the gonadotropins segment has contributed more than 41% of market share in 2023.
- By the drug class, the selective estrogen receptor modulators segment is predicted to show rapid growth in the market.
- By the distribution channel, the hospital pharmacy segment has generated more than 55% of market share in 2023.
- By distribution channel, the online pharmacy segment is expected to grow at a high rate over the forecast period.
- By end-user, the women segment has contributed more than 74% of market share in 2023.
- By end-user, the men segment will be the fastest-growing segment during the forecast period.
The global infertility drugs market is experiencing steady growth due to increasing infertility rates globally and advancements in reproductive medicine. Infertility drugs are pharmaceuticals used to treat various causes of infertility, such as hormonal imbalances, ovulation disorders, and male factor infertility. This market encompasses a range of medications including gonadotropins, anti-estrogens, and others aimed at improving fertility outcomes. The market is driven by rising awareness, changing lifestyles, and the growing acceptance of assisted reproductive technologies (ART) worldwide.
Get a Sample: https://www.precedenceresearch.com/sample/4243
Growth Factors
The growth of the infertility drugs market is primarily fueled by technological advancements in fertility treatments and diagnostic techniques. Increasing prevalence of lifestyle-related factors impacting fertility, such as obesity and stress, is also contributing to market expansion. Moreover, growing investment in research and development to introduce novel drug therapies with improved efficacy and safety profiles is expected to drive market growth over the forecast period.
Region Insights
Regionally, North America and Europe dominate the infertility drugs market owing to higher healthcare expenditure, advanced healthcare infrastructure, and increasing adoption of fertility treatments. Asia-Pacific is emerging as a lucrative market due to rising awareness, improving healthcare infrastructure, and growing disposable income levels. In contrast, regions like Latin America and the Middle East are witnessing gradual market growth, propelled by increasing access to infertility treatments and supportive government initiatives.
Infertility Drugs Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 6.13% |
| Global Market Size in 2023 | USD 3.71 Billion |
| Global Market Size in 2024 | USD 3.94 Billion |
| Global Market Size by 2033 | USD 6.73 Billion |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Drug Class, By Distribution Channel, and By End-user |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Infertility Drugs Market Dynamics
Drivers
Key drivers of the infertility drugs market include rising infertility rates attributed to factors like delayed parenthood, lifestyle changes, and environmental factors. Additionally, the expanding applications of ART and the growing trend of single parenthood are boosting the demand for infertility drugs. Furthermore, favorable reimbursement policies for infertility treatments in certain regions are facilitating market growth and encouraging patients to seek medical intervention.
Opportunities
The infertility drugs market presents significant opportunities for market players to expand their product portfolios and enter untapped markets. Collaborations between pharmaceutical companies and fertility clinics can enhance product accessibility and patient outreach. Furthermore, innovative drug delivery systems and personalized medicine approaches tailored to individual patient needs offer promising avenues for market growth and differentiation.
Challenges
Despite growth prospects, the infertility drugs market faces challenges such as stringent regulatory requirements governing reproductive medicine and ethical considerations surrounding assisted reproductive technologies. Additionally, high treatment costs and limited insurance coverage in certain regions pose barriers to market expansion. Furthermore, the social stigma associated with infertility in some cultures may hinder patient acceptance of infertility treatments and impact market growth.
Read Also: Calcium Peroxide Market Size to Surpass USD 3.38 Bn By 2033
Infertility Drugs Market Recent Developments
- In February 2024, Lupin, a major global pharma company, launched Ganirelix Acetate Injection. It is a single-dose prefilled syringe indicated for inhibiting premature luteinizing hormone (LH) surges in women who undergo ovarian hyperstimulation.
- In March 2024, Future Generali India Insurance launched ‘Health PowHER’, a product designed exclusively for women healthcare at various stages of their lives. There will be varios treatments offered by the product, and one of the treatments will be infertility treatment. This will include oocyte cryopreservation, stem cell storage, wellness programme, insurance for newborn defects, nursing care, and many more benefits.
Infertility Drugs Market Companies
- Merck & Co., Inc.
- Ferring B.V.
- Organon Group of Companies
- Abbott
- Novartis AG
- Bayer AG
- Pfizer Inc.
- Mankind Pharma
- Teva Pharmaceutical Industries LTD.
- Sanofi
Segments Covered in the Report
By Drug Class
- Gonadotropins
- Aromatase Inhibitors
- Selective Estrogen Receptor Modulators (SERMs)
- Dopamine Agonists
- Others
By Distribution Channel
- Hospital Pharmacy
- Specialty & Retail Pharmacy
- Online Pharmacy
By End-user
- Men
- Women
By Geography
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East & Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
